01 1Synthon Pharmaceuticals
01 1SUGAMMADEX OCTASODIUM
01 1Netherlands
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-10-31
Pay. Date : 2019-07-08
DMF Number : 33987
Submission : 2019-07-10
Status : Active
Type : II
20
Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SUGAMMADEX OCTASODIUM, with a corresponding US DMF Number 33987.
Remarkably, this DMF maintains an Active status since its submission on July 10, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2019, and payment made on July 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
